Media Room Menu
Powerful New Efficacy Data In Moderate And Severe Hypertensive Patients Supports FDA Approval Of Avalide® (Irbesartan-Hydrochlorothiazide) As The First Combination Therapy For Initial Use In Patients Likely To Need Multiple Drugs To Achieve Their Blood Pr
